Zemplar Related Clinical Trials
Paricalcitol Injection Phase II Trial [Completed]
A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection [Completed]
A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis [Completed]
A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors [Recruiting]
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis [Recruiting]
Oral Paricalcitol in Kidney Transplant Recipients [Recruiting]
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects [Completed]
Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis [Terminated]
The PRIMO Study-Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Chronic Kidney Disease Stage 3B/4 [Recruiting]
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation [Recruiting]
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With CKD Stage 5 [Recruiting]
Long-Term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With HD [Not yet recruiting]
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients [Completed]
Vitamin D and Coronary Calcification Study [Recruiting]
A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis [Completed]
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium [Completed]
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects [Not yet recruiting]
Dose-Response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis (HD) [Recruiting]
Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis [Completed]
Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer [Recruiting]
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Recruiting]
Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer [Recruiting]
Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis [Completed]
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases [Not yet recruiting]
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [Completed]
Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [Completed]
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy [Not yet recruiting]
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) [Completed]
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease [Recruiting]
Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis [Completed]
Paricalcitol in Treating Patients With Myelodysplastic Syndrome [Active, not recruiting]
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism [Completed]
Treatment of Secondary Hyperparathyroidism in the Uremic Patient [Recruiting]
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-Linked Hypophosphatemic Rickets [Recruiting]
A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease [Recruiting]
Vitamin D, Insulin Resistance and Inflammation in ESRD [Recruiting]
Immune Effects of Vitamin D in Hemodialysis Patients [Completed]
Comparison of Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Stage Three and Four [Recruiting]
|
